Curis | CRIS - Passifs Courants





Passifs Courants Changement Date
Alaunos Therapeutics USD 595K 218K 2026-03
Amgen USD 25.5B 547M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bayer EUR 32.27B 1.19B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
CSL USD 4.61B 207M 2025-12
Curis USD 14.97M 898K 2026-03
Eli Lilly USD 47.74B 11.11B 2026-06
Exelixis USD 361.93M 9.05M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Incyte USD 1.31B 177.55M 2026-06
Merck USD 27.73B 786M 2026-06
Novartis USD 31.75B 374M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Takeda JPY 2.76T 335.02B 2026-06
TG Therapeutics USD 268.49M 81.38M 2026-06
Verastem USD 66.84M 5.42M 2026-03